Mun Pharma Stock Slides 2.5% as Investors Weigh Gaming Strategy & 52‑Week Outlook
Analyze Munar Pharma’s April 2026 stock dip: 2.5% decline, near 200‑day SMA, mixed peer trends, and its gaming‑finance hybrid strategy.
3 minutes to read
MUNAR PHARMA SA